Xuan Cao
4PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Dec 09, 2023
Blockade of DDR1/PYK2/ERK signaling suggesting SH2 superbinder as a novel autophagy inhibitor for pancreatic cancer.Hui Xu, Ming Tan, Guo-Qing Hou
|Oct 13, 2021
Src acts as the target of matrine to inhibit the proliferation of cancer cells by regulating phosphorylation signaling pathways.Xi Zhang, Hui Xu, Xiaoyang Bi
|Jul 16, 2021
Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARĪ± pathway.Lin Xu, Xinge Zhang, Yue Xin
|Mar 30, 2021
Aptamer-SH2 superbinder-based targeted therapy for pancreatic ductal adenocarcinoma.An-Dong Liu, Jie Zhou, Xiao-Yang Bi
Pageof 1
